THRESHOLD PHARMACEUTICAL INC's ticker is THLD and the CUSIP is 885807206. A total of 83 filers reported holding THRESHOLD PHARMACEUTICAL INC in Q4 2014. The put-call ratio across all filers is 0.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $2,000 | -33.3% | 4,877 | 0.0% | 0.00% | – |
Q1 2017 | $3,000 | -50.0% | 4,877 | -62.1% | 0.00% | – |
Q4 2016 | $6,000 | -70.0% | 12,877 | -56.0% | 0.00% | – |
Q3 2016 | $20,000 | +42.9% | 29,271 | +31.6% | 0.00% | – |
Q2 2016 | $14,000 | -17.6% | 22,247 | -40.8% | 0.00% | – |
Q1 2016 | $17,000 | 0.0% | 37,570 | +4.0% | 0.00% | – |
Q4 2015 | $17,000 | -84.1% | 36,120 | +37.1% | 0.00% | -100.0% |
Q3 2015 | $107,000 | +181.6% | 26,353 | +181.0% | 0.00% | 0.0% |
Q2 2015 | $38,000 | -5.0% | 9,377 | -3.9% | 0.00% | 0.0% |
Q1 2015 | $40,000 | -68.0% | 9,758 | -75.3% | 0.00% | -50.0% |
Q4 2014 | $125,000 | -53.7% | 39,461 | -47.1% | 0.00% | -50.0% |
Q3 2014 | $270,000 | +103.0% | 74,653 | +122.2% | 0.00% | +100.0% |
Q2 2014 | $133,000 | -46.8% | 33,604 | -36.0% | 0.00% | -50.0% |
Q1 2014 | $250,000 | +190.7% | 52,491 | +183.9% | 0.00% | +300.0% |
Q4 2013 | $86,000 | +514.3% | 18,488 | +536.4% | 0.00% | – |
Q3 2013 | $14,000 | -83.9% | 2,905 | -82.3% | 0.00% | -100.0% |
Q2 2013 | $87,000 | – | 16,453 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DAFNA Capital Management LLC | 625,558 | $2,540,000 | 1.95% |
CG Asset Management LLC | 128,000 | $520,000 | 0.20% |
Rotella Capital Management, Inc. | 45,364 | $184,000 | 0.15% |
TFS CAPITAL LLC | 348,617 | $1,415,000 | 0.14% |
Rhenman & Partners Asset Management AB | 201,537 | $818,000 | 0.14% |
FORTALEZA ASSET MANAGEMENT INC/ | 59,180 | $240,000 | 0.14% |
Baker Brothers Advisors | 2,925,519 | $11,878,000 | 0.10% |
FEDERATED HERMES, INC. | 3,918,305 | $15,908,000 | 0.05% |
FRANKLIN STREET ADVISORS INC /NC | 50,000 | $203,000 | 0.04% |
Princeton Alpha Management LP | 26,560 | $108,000 | 0.02% |